Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

UnitedHealth Group (NY:UNH)

379.65 -0.99 (-0.26%)
Streaming Delayed Price Updated: 10:32 AM EDT, May 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about UnitedHealth Group

< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
84 85 Next >
Healthcare Stocks Are Coming On Strong In July Led By Biotech
The biotech rally gained momentum in July with rotation out of technology stocks. 
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Leading Healthcare Provider Stock Soars on Earnings Beat
Molina Healthcare's Q2 earnings and strategic acquisitions fuel a surge in its stock price, signaling the potential for continued growth. 
Via MarketBeat
Topics Earnings
Exposures Financial
3 Value Stocks to Buy on the Dip: July 2024
Investors should keep an eye on these value stocks that look ripe for the picking amid the current market downturn. 
Via InvestorPlace
Got $5,000? These 3 Growth Stocks Are Incredibly Cheap Buys Right Now
These stocks all trade at forward price-to-earnings multiples of 20 or less. 
Via The Motley Fool
Industry Comparison: Evaluating UnitedHealth Group Against Competitors In Health Care Providers &amp; Services Industry
Via Benzinga
What the Options Market Tells Us About UnitedHealth Group
Via Benzinga
Market Whales and Their Recent Bets on UNH Options
Via Benzinga
Here's How Much You Would Have Made Owning UnitedHealth Group Stock In The Last 5 Years
Via Benzinga
This Ultra-High-Yield Dividend Stock Hits Yet Another Setback
Medical Properties Trust's top tenant is struggling to sell assets. 
Via The Motley Fool
3 Russell Stocks To Buy Before The Potential Upcoming Rally
Depending on political winds favoring former President Trump, small caps, industrials, and financials should see a surge. 
Via Talk Markets
Topics Government
Exposures Political
Trump's Election Prospects Look Brighter — And So Do These Industries And Stocks
A potential return to the White House by Trump is scrambling stocks as investors consider sectors that might benefit from a Trump victory. 
Via Investor's Business Daily
Topics Government
Exposures Political
2 Beaten-Down Dividend Stocks With Ultra-High Yields Above 9%: Are They Bargains Now?
Find out if the huge yields these pressured dividend payers offer could be worth the risk. 
Via The Motley Fool
Analyst Scoreboard: 15 Ratings For UnitedHealth Group
Via Benzinga
Biden's Exit From Presidential Race 'Yet Another Curveball For Equity Investors': Analysts
President Biden's decision to drop out may harm healthcare and create market volatility. Kamala Harris could defend his record and support Medicare for All. 
Via Benzinga
AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?
The big pharma company's top drug is losing ground, but its dividend keeps rising. 
Via The Motley Fool
Prediction: These 3 Stocks Will Soar if Trump Wins in November
Trump's likely policies in a potential second term could provide catalysts for these stocks. 
Via The Motley Fool
Topics Government
Exposures Political
Warner Bros. Discovery & Coinbase Are Among 10 Large Cap Stocks That Shined Most Last Week (July 14-July 20): Are The Others In Your Portfolio?
Top performers last week: $WBD up 18.28%, $MSTR up 16.74%, $DHI up 12.91%, $COIN up 12.39%, $OQL up 7.89%, $UNH up 7.84%, $STT up 7.21%, $LEN up 7.07%, $TOST up 7.05%, $EPAM up 6.97%. Are they in your... 
Via Benzinga
3 Best Dividend Growth Plays in July 2024
Explore dividend growth stocks for long-term financial stability, backed by multiple years of reliable and growing dividend payments 
Via InvestorPlace
UnitedHealth Group Rallies Despite Continued Cyberattack Cost Pressures. Is It Too Late to Buy the Stock?
Why the stock rallied despite a mixed earnings report. 
Via The Motley Fool
3 Dow Stocks to Buy Now: Q3 Edition
The Dow stocks may be in a good spot to shine as the tech trade slips off its highs going into August and September. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Is This Telehealth Stock a Buy After the Recent Pullback?
Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions. 
Via MarketBeat
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
The Nasdaq tumbled amid chip woes. 
Via Investor's Business Daily
BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations
Elevance Health reports Q2 revenues of $43.2 billion, slightly above consensus despite a 0.4% YoY decline driven by Medicaid membership attrition. Analysts express concerns over ongoing Medicaid margin... 
Via Benzinga
3 Cybersecurity Stocks That Could Grow Your Wealth
Consider purchasing these cybersecurity stocks as they march higher, propelled by strong financial results. 
Via InvestorPlace
UnitedHealthcare Selected by the State of Rhode Island to Continue Serving Medicaid Members
From UnitedHealthcare
Via Business Wire
Dow Jones Extends All-Time Highs: Blue Chips Post Strongest 6-Day Gain Versus Tech Stocks In 22 Years
Dow Jones has risen by 5% over the last six sessions. Meanwhile, the tech-heavy Nasdaq 100 fell by 3.3%. Here's the latest. 
Via Benzinga
Topics Stocks
Exposures US Equities
Healthcare Investors Bet On Easier Medicare Rules Under Potential Trump Administration
Investors expect Trump to ease Medicare Advantage regulations if he wins another term. This could lead to renewed merger talks among health insurers. 
Via Benzinga
Topics Government
Exposures Political
UnitedHealth Reports 'Noisy' Quarterly Results: 5 Analysts Weigh In On 'Compelling Levers Of Improvement' For 2025
The stock rally post second-quarter results reflects low expectations heading into the quarter as well as "optimism on the bridge to 2025." 
Via Benzinga
Elevance Health Beat Street Estimates On Q2 Profit And Revenue, Sticks To Annual Guidance
Elevance Health surpasses Q2 profit and revenue estimates, reporting $43.2 billion in revenue and $2.3 billion in profit. Despite a 5% decline in medical membership due to Medicaid attrition, premium... 
Via Benzinga
< Previous 1 2
...
15 16 17 18 19 20 21 22 23
...
84 85 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.